drugset / Trial / NCT02410525

A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning

NCT02410525 ↗

Phase 1 Completed 8 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

In this study, radioactive PF-06427878 will be administered, through a vein, alone and with 2 different oral doses of non-radioactive PF-06427878 to healthy, adult, male subjects. Positron emission tomography will be used to characterize tissue distribution. The study will also characterize how the study drug behaves in the body, its safety, and how the body tolerates it.

Timeline

Start
2015-05
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06427878 Small molecule 20 ug Intravenous
Subject PF-06427878 Small molecule 10 mg Intravenous
Subject PF-06427878 Small molecule 600 mg Intravenous

Indications

No indication recorded.